Ep-CAM is a significant prognostic factor in pancreatic cancer patients by suppressing cell activity

Cellular Histone Modification Patterns Predict Prognosis and Treatment Response in Resectable Pancreatic Adenocarcinoma: Results From RTOG 9704

(2010) Ananya Manuyakorn et al.   JOURNAL OF CLINICAL ONCOLOGY

Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse

(2009) C Kahlert et al.   BRITISH JOURNAL OF CANCER

Activation of Wnt/β-catenin signalling pathway induces chemoresistance to interferon-α/5-fluorouracil combination therapy for hepatocellular carcinoma

(2009) T Noda et al.   BRITISH JOURNAL OF CANCER

Transcriptional Repression of Epithelial Cell Adhesion Molecule Contributes to p53 Control of Breast Cancer Invasion

(2009) N. V. Sankpal et al.   CANCER RESEARCH

EpCAM Is Involved in Maintenance of the Murine Embryonic Stem Cell Phenotype

(2009) Bárbara González et al.   STEM CELLS

EpCAM and  -Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma

(2008) T. Yamashita et al.   CANCER RESEARCH

Prognostic Effect of Epithelial Cell Adhesion Molecule Overexpression in Untreated Node-Negative Breast Cancer

(2008) M. Schmidt et al.   CLINICAL CANCER RESEARCH

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

(2008) Douglas B. Evans et al.   JOURNAL OF CLINICAL ONCOLOGY